Shiga Toxin‒Producing Escherichia coli Diagnoses from Health Practitioners, Queensland, Australia
In Queensland, Australia, 31 of 96 Shiga toxin‒producing Escherichia coli cases during 2020–2022 were reported by a specialty pathology laboratory servicing alternative health practitioners. Those new cases were more likely to be asymptomatic or paucisymptomatic, prompting a review of the standard...
| Published in: | Emerging Infectious Diseases |
|---|---|
| Main Authors: | Ashish C. Shrestha, Russell Stafford, Robert Bell, Amy V. Jennison, Rikki M.A. Graham, Emma Field, Stephen B. Lambert |
| Format: | Article |
| Language: | English |
| Published: |
Centers for Disease Control and Prevention
2024-01-01
|
| Subjects: | |
| Online Access: | https://wwwnc.cdc.gov/eid/article/30/1/23-1202_article |
Similar Items
Shiga Toxin–producing Escherichia coli Serotype O78:H in Family, Finland, 2009
by: Taru Lienemann, et al.
Published: (2012-04-01)
by: Taru Lienemann, et al.
Published: (2012-04-01)
Eculizumab for Shiga‐toxin‐induced hemolytic uremic syndrome in adults with neurological involvement
by: Benjamin J. Lee, et al.
Published: (2024-06-01)
by: Benjamin J. Lee, et al.
Published: (2024-06-01)
Diagnosis and Treatment for Shiga Toxin-Producing <i>Escherichia coli</i> Associated Hemolytic Uremic Syndrome
by: Yang Liu, et al.
Published: (2022-12-01)
by: Yang Liu, et al.
Published: (2022-12-01)
Case–Control Study of Factors Associated with Hemolytic Uremic Syndrome among Shiga Toxin–Producing Escherichia coli Patients, Ireland, 2017–2020
by: Diana Espadinha, et al.
Published: (2025-04-01)
by: Diana Espadinha, et al.
Published: (2025-04-01)
Household transmission and carriage of Shiga toxin-producing Escherichia coli (STEC) O145, Stx1c: a family report
by: Elif Okumuş, et al.
Published: (2025-07-01)
by: Elif Okumuş, et al.
Published: (2025-07-01)
Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. coli Infection: a multinational embedded cluster crossover randomized trial (the HIKO STEC trial)
by: Stephen B. Freedman, et al.
Published: (2023-05-01)
by: Stephen B. Freedman, et al.
Published: (2023-05-01)
INM004: Polyclonal Neutralizing Antibodies Against Shiga Toxin as a Treatment for Hemolytic Uremic Syndrome
by: Marta Rivas, et al.
Published: (2025-06-01)
by: Marta Rivas, et al.
Published: (2025-06-01)
Shiga Toxin 2a Induces NETosis via NOX-Dependent Pathway
by: Wouter J. C. Feitz, et al.
Published: (2021-12-01)
by: Wouter J. C. Feitz, et al.
Published: (2021-12-01)
The frequency of detection of markers of Сytomegalovirus infection in children with recurrent respiratory diseases in patients with Shiga-toxin-associated hemolytic-uremic syndrome (STEC-HUS)
by: I. B. Repina, et al.
Published: (2021-04-01)
by: I. B. Repina, et al.
Published: (2021-04-01)
Characterization of six Shiga toxin-producing Escherichia coli (STEC) strains carrying Stx2-phages from Colombia
by: Brayan Stiven Arango, et al.
Published: (2022-08-01)
by: Brayan Stiven Arango, et al.
Published: (2022-08-01)
Scalable Reporter Assays to Analyze the Regulation of <i>stx2</i> Expression in Shiga Toxin-Producing Enteropathogens
by: Martin B. Koeppel, et al.
Published: (2021-07-01)
by: Martin B. Koeppel, et al.
Published: (2021-07-01)
The Shiga Toxin Receptor Globotriaosylceramide as Therapeutic Target in Shiga Toxin <i>E. coli</i> Mediated HUS
by: Wouter J. C. Feitz, et al.
Published: (2021-10-01)
by: Wouter J. C. Feitz, et al.
Published: (2021-10-01)
Reduced Toxicity of Shiga Toxin (Stx) Type 2c in Mice Compared to Stx2d Is Associated with Instability of Stx2c Holotoxin
by: Joshua C. Bunger, et al.
Published: (2015-06-01)
by: Joshua C. Bunger, et al.
Published: (2015-06-01)
Molecular and in silico analyses for detection of Shiga toxin-producing Escherichia coli (STEC) and highly pathogenic enterohemorrhagic Escherichia coli (EHEC) using genetic markers located on plasmid, O Island 57 and O Island 71
by: Ali Nemati, et al.
Published: (2024-09-01)
by: Ali Nemati, et al.
Published: (2024-09-01)
Intestinal mucus-derived metabolites modulate virulence of a clade 8 enterohemorrhagic Escherichia coli O157:H7
by: Nicolás Garimano, et al.
Published: (2022-08-01)
by: Nicolás Garimano, et al.
Published: (2022-08-01)
Moving towards on-site detection of Shiga toxin-producing Escherichia coli in ready-to-eat leafy greens
by: Ana Costa-Ribeiro, et al.
Published: (2024-01-01)
by: Ana Costa-Ribeiro, et al.
Published: (2024-01-01)
Characteristics of Shiga Toxin-Producing <i>Escherichia coli</i> Circulating in Asymptomatic Food Handlers
by: Xinxia Sui, et al.
Published: (2023-11-01)
by: Xinxia Sui, et al.
Published: (2023-11-01)
Sporadic Shiga Toxin–Producing Escherichia coli–Associated Pediatric Hemolytic Uremic Syndrome, France, 2012–2021
by: Gabrielle Jones, et al.
Published: (2023-10-01)
by: Gabrielle Jones, et al.
Published: (2023-10-01)
Eculizumab is efficacious and safe in pediatric patients with various forms of hemolytic uremic syndrome: a retrospective clinical experience of a tertiary center
by: Naama Lax, et al.
Published: (2025-04-01)
by: Naama Lax, et al.
Published: (2025-04-01)
Use of complement C5-inhibitor eculizumab in patients with infection-associated hemolytic uremic syndrome – a case-series report
by: Petra Varga, et al.
Published: (2025-03-01)
by: Petra Varga, et al.
Published: (2025-03-01)
Bacteriophages of Shiga Toxin-Producing <i>Escherichia coli</i> and Their Contribution to Pathogenicity
by: Lorena Rodríguez-Rubio, et al.
Published: (2021-03-01)
by: Lorena Rodríguez-Rubio, et al.
Published: (2021-03-01)
Roles of Shiga Toxins in Immunopathology
by: Moo-Seung Lee, et al.
Published: (2019-04-01)
by: Moo-Seung Lee, et al.
Published: (2019-04-01)
Neurological Manifestations of Hemolytic Uremic Syndrome: A Comprehensive Review
by: Una Tonkovic, et al.
Published: (2025-07-01)
by: Una Tonkovic, et al.
Published: (2025-07-01)
The Role of the N-Terminal Domain of Thrombomodulin and the Potential of Recombinant Human Thrombomodulin as a Therapeutic Intervention for Shiga Toxin-Induced Hemolytic-Uremic Syndrome
by: Sarah Kröller, et al.
Published: (2024-09-01)
by: Sarah Kröller, et al.
Published: (2024-09-01)
Genetic Characterization of Intimin Gene (<i>eae</i>) in Clinical Shiga Toxin-Producing <i>Escherichia coli</i> Strains from Pediatric Patients in Finland
by: Lei Wang, et al.
Published: (2023-11-01)
by: Lei Wang, et al.
Published: (2023-11-01)
Pro-Coagulant Endothelial Dysfunction Results from EHEC Shiga toxins and Host Damage-Associated Molecular Patterns
by: Chad L Mayer, et al.
Published: (2015-04-01)
by: Chad L Mayer, et al.
Published: (2015-04-01)
Prevalence and molecular characterisation of Shiga toxin-producing Escherichia coli in sheep farms of Sanandaj, Iran
by: P. Ghaderi, et al.
Published: (2024-06-01)
by: P. Ghaderi, et al.
Published: (2024-06-01)
Epidemiological Characteristics of Shiga Toxin-Producing Escherichia coli Responsible for Infections in the Polish Pediatric Population
by: Seliga-Gąsior Dominika, et al.
Published: (2024-05-01)
by: Seliga-Gąsior Dominika, et al.
Published: (2024-05-01)
Method for the Detection of the Cleaved Form of Shiga Toxin 2a Added to Normal Human Serum
by: Lucrezia Rocchetti, et al.
Published: (2021-01-01)
by: Lucrezia Rocchetti, et al.
Published: (2021-01-01)
Gut–Kidney Axis on Chip for Studying Effects of Antibiotics on Risk of Hemolytic Uremic Syndrome by Shiga Toxin-Producing <i>Escherichia coli</i>
by: Yugyeong Lee, et al.
Published: (2021-11-01)
by: Yugyeong Lee, et al.
Published: (2021-11-01)
A Rapid and Sensitive Method to Measure the Functional Activity of Shiga Toxins in Human Serum
by: Valentina Arfilli, et al.
Published: (2015-11-01)
by: Valentina Arfilli, et al.
Published: (2015-11-01)
Detection of Shiga Toxins by Lateral Flow Assay
by: Kathryn H. Ching, et al.
Published: (2015-04-01)
by: Kathryn H. Ching, et al.
Published: (2015-04-01)
Switching Shiga Toxin (Stx) Type from Stx2d to Stx2a but Not Stx2c Alters Virulence of Stx-Producing <i>Escherichia coli</i> (STEC) Strain B2F1 in Streptomycin (Str)-Treated Mice
by: Beth A. McNichol, et al.
Published: (2021-01-01)
by: Beth A. McNichol, et al.
Published: (2021-01-01)
First isolation in Argentina of a highly virulent Shiga toxin-producing Escherichia coli O145:NM from a domestic cat
by: María Valeria Rumi, et al.
Published: (2012-02-01)
by: María Valeria Rumi, et al.
Published: (2012-02-01)
Prevalence of Shiga Toxin-Producing Escherichia coli (STEC) and Risk Characterization Based on Virulence Genes in Retail Raw Ground Meat of Beef, Veal, and Lamb in Canada
by: Helen Zhang, et al.
Published: (2025-04-01)
by: Helen Zhang, et al.
Published: (2025-04-01)
Combined Action of Shiga Toxin Type 2 and Subtilase Cytotoxin in the Pathogenesis of Hemolytic Uremic Syndrome
by: Romina S. Álvarez, et al.
Published: (2021-07-01)
by: Romina S. Álvarez, et al.
Published: (2021-07-01)
Shiga Toxin-Producing <i>Escherichia coli</i> Strains from Romania: A Whole Genome-Based Description
by: Codruța-Romanița Usein, et al.
Published: (2024-07-01)
by: Codruța-Romanița Usein, et al.
Published: (2024-07-01)
Ruminant-dense environments increase risk of reported Shiga toxin-producing Escherichia coli infections independently of ruminant contact
by: Caitlin Ward, et al.
Published: (2025-02-01)
by: Caitlin Ward, et al.
Published: (2025-02-01)
Diversity of Shiga toxin transducing phages in Escherichia coli O145:H28 and the different Shiga toxin 2 production levels associated with short- or long-tailed phages
by: Keiji Nakamura, et al.
Published: (2024-08-01)
by: Keiji Nakamura, et al.
Published: (2024-08-01)
Shiga toxin-associated hemolytic uremic syndrome complicated by intestinal perforation in a child with typical hemolytic uremic syndrome
by: Hye Jin Chang, et al.
Published: (2014-02-01)
by: Hye Jin Chang, et al.
Published: (2014-02-01)
Similar Items
-
Shiga Toxin–producing Escherichia coli Serotype O78:H in Family, Finland, 2009
by: Taru Lienemann, et al.
Published: (2012-04-01) -
Eculizumab for Shiga‐toxin‐induced hemolytic uremic syndrome in adults with neurological involvement
by: Benjamin J. Lee, et al.
Published: (2024-06-01) -
Diagnosis and Treatment for Shiga Toxin-Producing <i>Escherichia coli</i> Associated Hemolytic Uremic Syndrome
by: Yang Liu, et al.
Published: (2022-12-01) -
Case–Control Study of Factors Associated with Hemolytic Uremic Syndrome among Shiga Toxin–Producing Escherichia coli Patients, Ireland, 2017–2020
by: Diana Espadinha, et al.
Published: (2025-04-01) -
Household transmission and carriage of Shiga toxin-producing Escherichia coli (STEC) O145, Stx1c: a family report
by: Elif Okumuş, et al.
Published: (2025-07-01)
